Suppr超能文献

根治性肾切除术及肿瘤血栓切除术中原发性下腔静脉修复的通畅结果。

Patency outcomes of primary inferior vena cava repair in radical nephrectomy and tumor thrombectomy.

作者信息

Garg Harshit, Whalen Philip, Marji Haneen, Cooper Robert, Dursun Furkan, Bhandari Mukund, Khanna Lokesh, Jayakumar Lalithapriya, Liss Michael A, Svatek Robert S, Rodriguez Ronald, Kaushik Dharam, Pruthi Deepak K

机构信息

Department of Urology, University of Texas Health, San Antonio, TX.

University of the Incarnate Word School of Osteopathic Medicine, San Antonio, TX.

出版信息

J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):595-604.e2. doi: 10.1016/j.jvsv.2023.01.004. Epub 2023 Feb 2.

Abstract

OBJECTIVE

The reconstruction of inferior vena cava (IVC) during radical nephrectomy and venous tumor thrombectomy (RN-VTT) is mostly performed with primary repair or with a patch/graft. We sought to systematically evaluate the outcomes of IVC patency over short- to intermediate-term follow-up for patients undergoing primary repair of IVC and to assess the association with survival.

METHODS

A retrospective review of patients undergoing RN-VTT between January 2013 and August 2018 was conducted. Patients were followed until death, last available follow-up, or March 2022. The patency outcomes and IVC diameters were studied using follow-up cross-sectional imaging. The χ test, Student t test, and Kaplan-Meier survival analysis were used.

RESULTS

Seventy-seven patients were included. The mean age was 59.2 ± 12.2 years and 45.4% had Mayo classification level III thrombus or higher. At a median follow-up of 36.5 months (13.3-60.7 months), the 3-year overall survival (OS) was 64%. Sixty patients underwent primary repair of the IVC and 48 of these patients were assessed for IVC patency. Ten patients (20.8%) developed caval occlusion, either from recurrent tumor (8.3%), new-onset bland thrombus (8.3%), or stenosis (4.2). The IVC patency seemed to be a significant predictor of OS (hazard ratio, 2.85; P = .021). Although the IVC diameters decreased significantly at the 3-month postoperative scan at the infrarenal (P = .019), renal (P < .001), and suprarenal (P < .001) levels, they did not decrease further on long-term follow-up imaging.

CONCLUSIONS

IVC reconstruction with primary repair results in an overall patency rate of 80.2% with only a 4.0% rate of stenosis. Recurrence of tumor thrombus (8.3%) or bland thrombus (8.3%) are the predominant reasons for IVC occlusion after RN-VTT, and this outcome is associated with poor OS.

摘要

目的

根治性肾切除术联合静脉肿瘤血栓切除术(RN-VTT)期间下腔静脉(IVC)重建大多采用一期修复或补片/移植物修复。我们试图系统评估接受IVC一期修复患者在短期至中期随访中的IVC通畅情况,并评估其与生存率的相关性。

方法

对2013年1月至2018年8月期间接受RN-VTT的患者进行回顾性研究。对患者进行随访直至死亡、最后一次可用随访或2022年3月。使用随访横断面成像研究通畅情况和IVC直径。采用χ检验、学生t检验和Kaplan-Meier生存分析。

结果

纳入77例患者。平均年龄为59.2±12.2岁,45.4%患者的梅奥分类为III级血栓或更高。中位随访时间为36.5个月(13.3 - 60.7个月),3年总生存率(OS)为64%。60例患者接受了IVC一期修复,其中48例患者接受了IVC通畅情况评估。10例患者(20.8%)出现腔静脉闭塞,原因包括肿瘤复发(8.3%)、新发单纯性血栓(8.3%)或狭窄(4.2%)。IVC通畅似乎是OS的一个重要预测因素(风险比,2.85;P = 0.021)。虽然术后3个月扫描时肾下(P = 0.019)、肾(P < 0.001)和肾上(P < 0.001)水平的IVC直径显著减小,但在长期随访成像中并未进一步减小。

结论

一期修复IVC重建的总体通畅率为80.2%,狭窄率仅为4.0%。肿瘤血栓复发(8.3%)或单纯性血栓(8.3%)是RN-VTT后IVC闭塞的主要原因,这一结果与较差的OS相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验